All lobbying filings

Arnold & Porter Kaye Scholer LLP

Arnold & Porter Kaye Scholer LLP filed a Q3 report for Genetix Biotherapeutics, Inc. on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for Genetix Biotherapeutics, Inc. · Biotechnology and pharmaceutical company.

As filed: ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.

All filings by Arnold & Porter Kaye Scholer LLP · Everything Genetix Biotherapeutics, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Pharmacy

Issues related to regulatory incentives for rare disease therapies.

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.